Regarding kidney function, apixaban reduced the risk of stroke/SE by 37% in those with an eGFR of <30 ml/min/1.73 m 2 (aHR: 0.63; 95% CI: 0.40–0.98; p = 0.04). Conclusions: Compared to warfarin, ...

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

Baseline characteristics according to apixaban dose in subgroups with three different dose reduction criteria. The apixaban dosing pattern in each subgroup according to dose reduction criteria (age, ...

The RENAL-AF trial (Renal Hemodialysis Patients Allocated Apixaban Versus Warfarin in Atrial Fibrillation) was a prospective, randomized, open-label, blinded-outcome evaluation (PROBE) of apixaban ...

1. In comparison to rivaroxaban, apixaban was associated with a lower rate of bleeding events and embolic events amongst adults with both atrial fibrillation (AF) and valvular heart disease (VHD). 2.

Apixaban -- metabolism, pharmacologic properties and drug interactions This article by Dr. Peter Kubisz et al. is published in Current Drug Metabolism, Volume 18, Issue 7, 2017 ...

Apixaban was associated with a lower risk of GIB for patients with chronic kidney disease or over 80 years old compared to dabigatran, edoxaban, or rivaroxaban. Evidence Rating Level: 1. 1. In this ...

Apixaban(Eliquis) generic is an anticoagulant, which is used for reducing the risk of strokes and blood clots in patients with atrial fibrillation who have no problems with their heart valve ...